Free Trial
CVE:VPT

VentriPoint Diagnostics (VPT) Stock Price, News & Analysis

VentriPoint Diagnostics logo
C$0.12 0.00 (0.00%)
As of 03:58 PM Eastern

About VentriPoint Diagnostics Stock (CVE:VPT)

Key Stats

Today's Range
C$0.11
C$0.12
50-Day Range
C$0.11
C$0.17
52-Week Range
C$0.08
C$0.20
Volume
164,071 shs
Average Volume
186,362 shs
Market Capitalization
C$18.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VentriPoint Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VPT Stock News Headlines

Why More Investors Are Using Family Trusts to Protect Their Wealth
For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026. If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest.tc pixel
Ventripoint Diagnostics Ltd. (VPT.V) - Yahoo Finance
See More Headlines

VPT Stock Analysis - Frequently Asked Questions

VentriPoint Diagnostics' stock was trading at C$0.10 at the start of the year. Since then, VPT shares have increased by 15.0% and is now trading at C$0.12.

Shares of VPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that VentriPoint Diagnostics investors own include Resverlogix (RVX), Meta Platforms (META), Sphere 3D (ANY), Aptose Biosciences (APTO), Antibe Therapeutics (ATE), AuRico Gold Inc. Ordinary Share (AUQ) and Baytex Energy (BTE).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
CVE:VPT
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$5.25 million
Net Margins
-3,732.10%
Pretax Margin
N/A
Return on Equity
388.60%
Return on Assets
-136.72%

Debt

Debt-to-Equity Ratio
-58.56
Current Ratio
0.28
Quick Ratio
6.67

Sales & Book Value

Annual Sales
C$140.67 thousand
Price / Sales
132.60
Cash Flow
C$0.02 per share
Price / Cash Flow
5.53
Book Value
C($0.02) per share
Price / Book
-7.36

Miscellaneous

Outstanding Shares
162,204,000
Free Float
N/A
Market Cap
C$18.65 million
Optionable
Not Optionable
Beta
0.39
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (CVE:VPT) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners